Increases in blood pressure in young adulthood precede the development of type 2 diabetes in middle age.
Read More »Issue 155 Item 7 A Country Limits Diabetes Dialysis Treatment!
Could this be in store for the U.S. and other countries?
Read More »Issue 157 Item 7 Repaglinide Vs. Nateglinide in Type 2 Diabetes
After 16 weeks of treatment, mean reductions of HbA1c were -1.6% for the repaglinide group and -1.0% for the nateglinide group.
Read More »Issue 156 Item 10 Researchers reported at the 18th Annual Scientific Meeting of
Rofecoxib significantly increased systolic blood pressure, while celecoxib (Celebrex) and naproxen did not.
Read More »Issue 150 Item 3 Blood Glucose Increase During Antihypertensive Treatment Increa
ACE-inhibitors or calcium antagonists may be better choices.
Read More »Issue 151 Item 2 Fasting BG Levels Linked With Smoking
Diabetic patients demonstrate and interaction between level of fasting glycemia, lung function and any past or present tobacco smoking.
Read More »Issue 154 Item 14 Fluid Retention Reversible In Diabetics Treated With TZD’s
Thiazolidinedione-induced fluid retention in diabetics with chronic systolic heart failure (HF) is likely to be peripheral and reversible after drug withdrawal
Read More »Issue 153 Item 14 Enormous Burden of Diabetes in Latin America and the Caribbean
Every year, more than 330,000 people die in the region of the Americas due to causes related to diabetes. Diabetes affects approximately 28 million people in the region One of the most serious problems in Latin America and the Caribbean, both in terms of public health and economic burden, is …
Read More »Skipping Meals May Help, Not Hurt, Health
New findings in mice suggest that skipping the occasional meal may be good for your health.
Read More »Issue 157 Item 9 Glycemic Optimization Improves Diabetic Dyslipidemia
A drop in A1c has a corresponding rise in HDL.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.